Young Kwang Chae, MD, discusses tumor-informed and tissue-agnostic ctDNA MRD assays in postsurgical lung cancer surveillance.
Young Kwang Chae, MD
Advertisement
Articles by Young Kwang Chae, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
FDA Approves Tucatinib Plus Trastuzumab/Pertuzumab as First-Line Maintenance in Advanced HER2+ Breast Cancer
2
FDA Approves Atezolizumab Plus Chemo for Stage III dMMR Colon Cancer
3
September Roundup of FDA Approvals in Oncology: 8 Decisions to Know
4
Individualized Neoantigen Vaccine Elicits Durable T-Cell Responses in Resected HPV– HNSCC
5